Insider Transactions in Q1 2023 at Aerovate Therapeutics, Inc. (AVTE)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 06
2023
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,250
-29.93%
|
$54,000
$24.33 P/Share
|
|
Mar 06
2023
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+25.83%
|
$2,250
$1.94 P/Share
|
|
Mar 06
2023
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
10,282
-98.95%
|
$246,768
$24.11 P/Share
|
|
Mar 06
2023
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
10,282
+46.68%
|
$10,282
$1.94 P/Share
|
|
Mar 01
2023
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
15,000
-63.2%
|
$360,000
$24.22 P/Share
|
|
Mar 01
2023
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$30,000
$2.14 P/Share
|
|
Feb 06
2023
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,250
-58.31%
|
$54,000
$24.27 P/Share
|
|
Feb 06
2023
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+25.83%
|
$2,250
$1.94 P/Share
|
|
Feb 06
2023
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
10,284
-93.07%
|
$246,816
$24.77 P/Share
|
|
Feb 06
2023
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
10,284
+46.68%
|
$10,284
$1.94 P/Share
|
|
Feb 01
2023
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
15,000
-85.02%
|
$330,000
$22.79 P/Share
|
|
Feb 01
2023
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$30,000
$2.14 P/Share
|
|
Jan 06
2023
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
10,284
-86.43%
|
$267,384
$26.29 P/Share
|
|
Jan 06
2023
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
10,284
+46.68%
|
$10,284
$1.94 P/Share
|
|
Jan 05
2023
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,250
-58.31%
|
$58,500
$26.4 P/Share
|
|
Jan 05
2023
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+25.83%
|
$2,250
$1.94 P/Share
|
|
Jan 03
2023
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
15,000
-87.86%
|
$420,000
$28.33 P/Share
|
|
Jan 03
2023
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$30,000
$2.14 P/Share
|